Jeff L Vacirca
CIK 1724161 · last filed 2026-08-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ODT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 510
SAN DIEGO, CA 92121
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CAI | Director | 62,863 | $23.02 | $1.45M | $501.4K | 3 | 2026-08-14 |
| Assertio Holdings, Inc. (ASRT) Delisted | Director | 10,077 | $23.50 | $236.8K | $11.1K | 3 | 2024-06-12 |
| SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Director | 0 | $1.03 | $0 | $22.5K | 20 | 2023-08-01 |
| Odonate Therapeutics, Inc. (ODT) Delisted | Director | 23,231 | $1.12 | $26.0K | $574.3K | 5 | 2019-06-28 |
Recent Filings · Page 2 of 4
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-02-14 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +10,000 | $6.8K | EDGAR |
| 2021-06-22 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +14,277 | $0 | EDGAR |
| 2021-04-08 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +20,000 | $63.0K | EDGAR |
| 2021-02-18 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +10,000 | $36.1K | EDGAR |
| 2020-12-28 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +10,000 | $37.9K | EDGAR |
| 2020-11-12 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +10,000 | $37.8K | EDGAR |
| 2020-09-17 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +1,000 | $4.2K | EDGAR |
| 2020-09-01 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +20,000 | $81.6K | EDGAR |
| 2020-06-30 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +8,000 | $25.7K | EDGAR |
| 2020-06-19 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +30,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).